Merck Exercised the Option for the Global Rights of Abbisko Therapeutics's Pimicotinib ...Middle East

SHANGHAI, March 31, 2025 /PRNewswire/ -- On April 1, 2025, Beijing Time, Abbisko Therapeutics Co., Ltd. ("Abbisko Therapeutics") announced that Merck has exercised the global commercialization option for pimicotinib (ABSK021), with an option exercise fee of USD85.0 million, under the...

Hence then, the article about merck exercised the option for the global rights of abbisko therapeutics s pimicotinib was published today ( Tuesday 01/04/2025 - 03:50 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Merck Exercised the Option for the Global Rights of Abbisko Therapeutics's Pimicotinib )

Also on site :

• Skier dies in collision with tree at Colorado’s Aspen Mountain, resort officials confirm
• Tornado warning issued, and quickly cancelled, over Alhambra
• Governor Hochul: Annual statewide donation drive is complete